15-23646357-GGGGGCCTGGCGGATCACGGGTGGGGCCTGGCGGATCACGGGT-GGGGGCCTGGCGGATCACGGGTGGGGCCTGGCGGATCACGGGTGGGGCCTGGCGGATCACGGGT
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM4BS1_SupportingBS2
The NM_019066.5(MAGEL2):c.1385_1386insACCCGTGATCCGCCAGGCCCC(p.Pro456_Pro462dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000556 in 143,848 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000056 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000033 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MAGEL2
NM_019066.5 inframe_insertion
NM_019066.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.10
Genes affected
MAGEL2 (HGNC:6814): (MAGE family member L2) Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_019066.5.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000556 (8/143848) while in subpopulation SAS AF= 0.000451 (2/4430). AF 95% confidence interval is 0.0000799. There are 0 homozygotes in gnomad4. There are 4 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEL2 | NM_019066.5 | c.1385_1386insACCCGTGATCCGCCAGGCCCC | p.Pro456_Pro462dup | inframe_insertion | 1/1 | ENST00000650528.1 | NP_061939.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEL2 | ENST00000650528.1 | c.1385_1386insACCCGTGATCCGCCAGGCCCC | p.Pro456_Pro462dup | inframe_insertion | 1/1 | NM_019066.5 | ENSP00000497810 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000556 AC: 8AN: 143778Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
143778
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000327 AC: 40AN: 1224066Hom.: 0 Cov.: 32 AF XY: 0.0000337 AC XY: 20AN XY: 592596
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
40
AN:
1224066
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
592596
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000556 AC: 8AN: 143848Hom.: 0 Cov.: 32 AF XY: 0.0000570 AC XY: 4AN XY: 70138
GnomAD4 genome
AF:
AC:
8
AN:
143848
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
70138
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Sep 29, 2023 | PM2, PM4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | This variant, c.1365_1385dup, results in the insertion of 7 amino acid(s) of the MAGEL2 protein (p.Pro456_Pro462dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MAGEL2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2085056). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In-frame duplication of 7 amino acids in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge - |
MAGEL2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The MAGEL2 c.1365_1385dup21 variant is predicted to result in an in-frame duplication (p.Pro456_Pro462dup). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at